Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Oct, 24 2025
Nov, 25 2025
Dec, 29 2025
Jun, 5 2025
Oct, 29 2025